Compliance guideRead at source, 28 September 2026
Pre-Employment Drug Screening: How to Set Up Testing That Holds Up (2026)
Pre-employment drug screening is a drug test an employer requires of a candidate, usually after a conditional offer. You decide the panel, the specimen, the timing and what a positive means, unless the role is DOT-regulated: for CDL drivers federal rules fix all of it. For everyone else the panel is your choice and state law, especially on cannabis, decides what you may act on.
How pre-employment drug screening works, step by step
Every program, DOT or not, runs the same five steps.
- Written policy. Which roles are tested, on what panel, at what point, and what a positive, a dilute or a refusal means. Our employee handbook template has a section to start from.
- Disclosure in the ad and the first contact. Say that the role requires a pre-employment drug screen before anyone applies.
- Conditional offer, then collection. Name the screen as a condition and send the candidate to collection the same day.
- Laboratory, then medical review. The lab screens and confirms; a medical review officer (MRO) checks non-negative results for a legitimate medical explanation before you see a positive.
- Decision and documentation. Act on the verified result, follow the notice process if the result came to you in a consumer report, and file the result away from the personnel file.
Drug panels: what a 5-panel and a 10-panel detect
Start with the one panel the law actually defines. Under 49 CFR 40.82 a laboratory must test every DOT specimen for five drugs or classes of drugs, marijuana metabolites, cocaine metabolites, amphetamines, opioids and phencyclidine (PCP), and “must not test ‘DOT specimens’ for any other drugs.” The cutoff table at 40.85 breaks those five into analytes, including codeine and morphine, hydrocodone and hydromorphone, oxycodone and oxymorphone, 6-acetylmorphine, amphetamine and methamphetamine, and MDMA and MDA. The marijuana screen is for the metabolite THCA at 50 ng/mL, confirmed at 15 ng/mL.
Outside DOT, “5-panel” and “10-panel” are laboratory product names, not legal categories. A non-DOT 5-panel is usually built around the same five classes; a 10-panel adds more, often prescription drug classes. Which ones varies by lab, so read the analyte list on your order rather than trusting the name.
| Panel | Who defines what is on it | What to check before ordering |
|---|---|---|
| DOT 5-panel | 49 CFR 40.82 and 40.85: five classes, fixed analytes and cutoffs, nothing else | Nothing to choose. You cannot add drugs to a DOT specimen |
| Non-DOT 5-panel | Your laboratory’s product sheet | Whether marijuana is on it, and whether you hire in a state that limits acting on a THC result |
| Non-DOT 10-panel or larger | Your laboratory’s product sheet | Which prescription classes it adds; those positives go to the MRO for a prescription check |
Specimen types: urine, oral fluid and hair
Urine
The default, and for DOT testing the only specimen actually in use today. Validity testing for dilution and adulteration (40.87) is where most retest delays come from.
Oral fluid: authorized for DOT since 2023, still not usable
DOT’s May 2023 final rule added oral fluid, and 49 CFR 40.210 now reads: “Both urine and oral fluid specimens are authorized for collection and testing under this part.” But 40.67(g)(5) adds the catch: “For an employer to use oral fluid testing, there must be at least two HHS-certified oral fluid drug testing laboratories.” The HHS list published on 1 September 2026 says: “At this time, there are no laboratories certified to conduct drug and specimen validity tests on oral fluid specimens.” DOT’s 11 May 2026 rule, effective 10 June 2026, keeps directly observed urine collections in place until that changes. So for a DOT pre-employment test in 2026, plan on urine. For non-DOT roles, oral fluid is a lab choice, subject to state rules.
Hair
Hair is not an option for DOT: 40.210 states that “hair testing, or instant tests are not authorized.” For non-DOT roles it is legal in most places but check the state first. California’s cannabis rule names hair expressly (below), and Nevada’s definition of a screening test covers “blood, urine, hair or saliva.”
When to test: after a contingent offer
Under 42 U.S.C. 12114(d)(1), “a test to determine the illegal use of drugs shall not be considered a medical examination,” so the ADA’s rule that medical exams wait until after an offer does not apply to it. Most employers still test after a conditional job offer: you only pay for tests on people you want, and the offer letter can name the screen as a condition.
The failure point is the gap: a candidate with no start date keeps interviewing. Order the collection the day of the offer and give a date you expect to confirm. Run the background check in parallel (for clinical roles, see healthcare background checks).
DOT-regulated vs non-DOT testing
For a CDL driver in a safety-sensitive role you are following a program, not designing one. Two federal duties come before the first shift:
- The test. Under 49 CFR 382.301(a), “No employer shall allow a driver, who the employer intends to hire or use, to perform safety-sensitive functions unless the employer has received a controlled substances test result from the MRO or C/TPA indicating a verified negative test result for that driver.”
- The Clearinghouse query. Under 382.701(a) you must run a full pre-employment query of the FMCSA Drug and Alcohol Clearinghouse, which “requires that the individual driver give specific consent.” See our FMCSA Clearinghouse guide.
Everything else for drivers, from random rates to post-accident clocks, is on DOT drug testing requirements, and the documents the result goes into are on the driver qualification file checklist. Non-DOT testing is everything else, and there state law sets the limits.
| DOT (CDL safety-sensitive) | Non-DOT | |
|---|---|---|
| Required? | Yes, before the first safety-sensitive function (382.301) | Only if your policy, contract or state rule requires it |
| Panel | Fixed five classes (40.82) | Your choice |
| Specimen | Urine; oral fluid authorized but no certified labs yet; no hair | Urine, oral fluid or hair, subject to state law |
| MRO review | Required | Strongly advisable; some states require it |
| State cannabis law | Does not override the federal rule | May bar acting on a THC result |
MRO review: what happens to a non-negative result
In DOT testing the MRO must be a licensed physician (40.121) and acts, in the regulation’s words, as an “independent and impartial ‘gatekeeper’” (40.123). Before releasing a confirmed positive, the MRO conducts a verification interview with the candidate (40.129), and under 40.137 must offer the person “an opportunity to present a legitimate medical explanation in all cases.” If there is one, the result is reported to you as negative.
Use an MRO for non-DOT testing too: it keeps prescription information away from the hiring manager, and the positive you act on has been verified by a physician.
Pre-employment drug test laws: the federal floor and the states
Federal law requires a pre-employment drug test only for DOT-regulated safety-sensitive roles. The ADA neither requires nor bans testing: 12114(d)(2) says nothing in it shall be construed to “encourage, prohibit, or authorize” drug testing of applicants. For other roles, pre-employment drug test laws are state laws, and the ones that bite hardest are about cannabis.
Cannabis: four states read at source
- California (Gov. Code 12954, the AB 2188 rule as amended by SB 700): unlawful to discriminate in hiring based on off-the-job cannabis use or on a screen that found “nonpsychoactive cannabis metabolites in their hair, blood, urine, or other bodily fluids.” Screens that do not test for those metabolites remain usable. Subdivision (b) also bars asking an applicant about prior cannabis use. Building and construction trades are excluded.
- Nevada (NRS 613.132): unlawful to “fail or refuse to hire a prospective employee because” a screening test indicates the presence of marijuana. Exceptions include firefighters, EMTs, driving roles where federal or state law requires testing, and positions that “in the determination of the employer, could adversely affect the safety of others.” An employee tested in the first 30 days may take a second test at their own expense to rebut it.
- New Jersey (P.L.2021, c.16, section 48, C.24:6I-52, as enacted): no refusal to hire because a person does or does not use cannabis items. Pre-employment testing is allowed, but the drug test the law describes pairs scientifically reliable testing with a physical evaluation of impairment.
- New York (Labor Law 201-d): protects legal cannabis use “prior to the beginning or after the conclusion of the employee’s work hours, and off of the employer’s premises.” An employer may still act where required by state or federal law, where the employee “manifests specific articulable symptoms while working,” or where acting otherwise would violate federal law or cost a federal contract or funding.
Our drug testing laws by state page groups sixteen jurisdictions that protect lawful off-duty use, eight that protect registered medical patients only, and the rest, with the exemptions that decide most frontline roles. Every one of the protective laws carves out roles covered by federal testing rules, so none of them changes a CDL driver’s DOT test.
Practical rule: if you hire outside DOT in a protective state, either drop THC from the panel for non-exempt roles or write down, per role, why the role is exempt. Deciding it after a positive comes back is the expensive order.
Adverse action after a positive result
Withdrawing the offer is the decision; the paperwork depends on how the result reached you. If a screening company delivered it as part of a background report, the Fair Credit Reporting Act’s two-notice sequence applies. The FTC’s guidance: “Before you take an adverse employment action, you must give the applicant or employee” a notice with a copy of the report and a summary of rights, then after the decision tell the person “that he or she was rejected because of information in the report.” Ask your vendor how results are delivered, and use the templates on our adverse action notice page.
For DOT drivers, the violation is reported to the Clearinghouse (382.705), and the driver may not perform safety-sensitive functions until the part 40 return-to-duty process is complete (382.503).
The ADA note: current use vs recovery
The ADA does not protect an applicant “currently engaging in the illegal use of drugs” (12114(a)). It does protect people who have completed or are in a supervised rehabilitation program and are no longer using, and people wrongly regarded as using (12114(b)). So act on a verified current positive, never on a history of treatment, and keep treatment questions out of the interview. Employers building a deliberate route for people in recovery can start at recovery-friendly workplace.
What a failed screen costs at the top of the funnel
We do not publish lab prices, because we could not verify them at a primary source. We can price the funnel a failed screen throws away. In Boostpoint’s 2026 Social Job Advertising Benchmark (891 managed Meta campaigns), CDL truck driver campaigns had a median cost per applicant of $26.86, middle half $17.00–$42.31, with an 8% apply rate; warehouse and production campaigns had a median of $9.83. Every candidate who fails or withdraws at the collection site was bought at that price.
The cheapest fix is disclosure in the ad and the first text; our CDL recruiting guide covers the rest of that funnel.
Frequently asked questions
What is pre-employment drug screening?
Pre-employment drug screening is a drug test an employer requires of a job candidate before they start work, usually after a conditional offer. It involves a specimen collection, a laboratory screen and confirmation, and review by a medical review officer. It is required for CDL drivers in safety-sensitive roles (49 CFR 382.301) and optional, within state law, for everyone else.
What does a 5-panel drug test detect?
The DOT test, the only panel defined in federal law, covers five classes: marijuana metabolites, cocaine metabolites, amphetamines, opioids and phencyclidine (49 CFR 40.82). A non-DOT 5-panel is usually built around the same classes, but its contents are set by the laboratory, so check the analyte list on your order.
What is the difference between a 5-panel and a 10-panel drug test?
A 10-panel adds more drug classes, often prescription ones. Outside DOT both are laboratory product names, and the analytes vary by lab. A DOT test cannot be expanded: 49 CFR 40.82 bars testing DOT specimens for any drugs beyond the five classes.
Can DOT pre-employment tests use oral fluid?
On paper, yes: 49 CFR 40.210 has authorized oral fluid since the 2023 rule. In practice, not yet. Section 40.67(g)(5) requires at least two HHS-certified oral fluid laboratories, and the HHS list published on 1 September 2026 said no laboratories were certified for oral fluid. Plan on urine for DOT tests.
Is hair testing allowed for pre-employment screening?
Not for DOT-regulated roles: 49 CFR 40.210 states that hair testing is not authorized. For non-DOT roles it is generally a lab choice, but check state law first. California bars acting on a screen that found nonpsychoactive cannabis metabolites in hair, blood, urine or other bodily fluids, and Nevada’s cannabis rule covers hair tests too.
Should the drug test come before or after the job offer?
The ADA does not require it to wait: 42 U.S.C. 12114(d)(1) says a test for illegal drug use is not a medical examination. Most employers still test after a conditional offer, so they only pay for candidates they want and the offer letter can name the screen as a condition.
What are the pre-employment drug test laws for non-DOT employers?
Federal law does not require non-DOT employers to test, and the ADA neither requires nor bans it. State law sets the rules, most sharply on cannabis. California, Nevada, New Jersey and New York all limit acting on off-duty cannabis use or a THC result for non-exempt roles. Our drug testing laws by state page groups every state.
Do state marijuana laws apply to CDL drivers?
No. Each protective state law we read carves out roles where federal or state law requires testing, and DOT rules still require marijuana metabolites on every DOT panel. A CDL driver in a safety-sensitive role needs a verified negative result under 49 CFR 382.301 and a full Clearinghouse query under 382.701 before the first safety-sensitive shift.
What does the medical review officer do?
The MRO is a licensed physician who reviews confirmed non-negative results before you see them. In DOT testing the MRO must interview the candidate and offer an opportunity to present a legitimate medical explanation, such as a valid prescription; if one exists, the result is reported as negative.
What should an employer do after a positive pre-employment drug test?
Act only on a result verified by the MRO, and check your state and role exemptions if the positive is for marijuana. If the result came from a screening company in a background report, follow the FCRA sequence: a pre-adverse action notice with the report and summary of rights, then an adverse action notice. For DOT drivers, the violation is also reported to the Clearinghouse.
Every failed screen sends you back to the top of the funnel.
We run Facebook and Instagram job ads for drivers, warehouse, trades and care roles, with the screen disclosed up front, so a failed test is a short delay rather than an empty requisition.
Book a DemoSources: 49 CFR 40.67, 40.82, 40.85, 40.87, 40.121–40.137, 40.210, 382.301, 382.503, 382.701 and 382.705 (eCFR, current to 25 September 2026); HHS Current List of HHS-Certified Laboratories, Federal Register 1 September 2026 (2026-17852); DOT final rule, 91 FR, 11 May 2026 (2026-09290); 42 U.S.C. 12114; California Government Code 12954; Nevada NRS 613.132; New Jersey P.L.2021, c.16, section 48; New York Labor Law 201-d; FTC, Background Checks: What Employers Need to Know; Boostpoint 2026 Social Job Advertising Benchmark. General information, not legal advice. Read at source 28 September 2026.